Shionogi and Egalet have entered a deal worth up to $425 million for the development of abuse-deterrent opioid painkillers, Egalet said.
Mylan has settled a patent-infringement lawsuit filed by Shionogi over its generic version of a drug for diabetes, Mylan said.
The Food and Drug Administration has approved a drug for postmenopausal women who experience pain during sex.
Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said.
Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.
The Food and Drug Administration has accepted a regulatory approval application for a drug made by Shionogi for treating vulvar and vaginal atrophy due to menopause.
Watson Pharmaceuticals announced the launch of an authorized generic version of a drug used to lower blood glucose in patients with Type 2 diabetes.
Prasco Labs has launched an authorized generic version of a blood-pressure drug made by Shionogi, the company said.
The Generic Pharmaceutical Association has named Ralph Neas as its new president and CEO.
Prasco will market an authorized generic drug for urinary tract infections under an agreement with Shionogi, the company said Monday.
Prasco Labs has contracted to sell an authorized generic version of a painkiller made by Shionogi, Prasco said Monday.
A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.
A treatment made by Shionogi for chronic, severe drooling in children and teenagers with neurological conditions has become available, the drug maker said Thursday.
Drug maker Shionogi has launched a new medication for attention deficit hyperactivity disorder, the company said Monday.
The Food and Drug Administration has approved a nonstimulant drug for treating attention deficit hyperactivity...